Xeomin™, the newest botulism toxin to the U.S. market, has arrived with, well, less than a bang. In 2012, marketing issues prevented the formal “marketing” launch of this new neurotoxin to the U.S. This product is a direct competitor with Dysport® and Botox® Cosmetic. Initial studies have shown that it may take less time to see the initial results from Xeomin® when compared to other neurotoxins, although most patients will see results for approximately 3 months, similar to both Botox® Cosmetic and Dysport®.
